Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Health care delivery for coronary heart disease in India--Where are we headed?

× No keyword cloud information.

8 in total

1. The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate.

Authors: Gajendra Kumar; Amita Srivastava; Surinder Kumar Sharma; Yogendra Kumar Gupta
Journal: J Ayurveda Integr Med Date: 2013-07

2. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.

Authors: Krishna K Sharma; Rajeev Gupta; Aachu Agrawal; Sanjeeb Roy; Atul Kasliwal; Ajeet Bana; Ravindra K Tongia; Prakash C Deedwania
Journal: Vasc Health Risk Manag Date: 2009-11-23

3. Three-year data from the XIENCE V INDIA study: safety and efficacy of XIENCE V in 1000 real world Indian patients.

Authors: Ashok Seth; Tejas M Patel; Marrianne Stuteville; Ravindra Kumar; Ajit S Mullasari; Upendra Kaul; Rony Mathew; A Sreenivas Kumar; Shih-Wa Ying; Krishnankutty Sudhir
Journal: Indian Heart J Date: 2014-04-18

4. The study of lipid profile, diet and other cardiovascular risk factors in children born to parents having premature ischemic heart disease.

Authors: Mr Savitha; B Sandeep
Journal: Indian J Community Med Date: 2011-10

5. Correlation of corrected QT dispersion with the severity of coronary artery disease detected by SYNTAX score in non-diabetic patients with STEMI.

Authors: Hatem Helmy; Ahmed Abdel-Galeel; Yehia Taha Kishk; Khaled Mohammed Sleem
Journal: Egypt Heart J Date: 2017-01-26

6. Assessment of Right Ventricular Function in Patients With Acute Myocardial Infarction.

Authors: Praveen K Baghel; Sunil K Tripathi; Althaf A Vahab; Puneet Aggarwal
Journal: Cureus Date: 2022-02-20

7. Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical study.

Authors: Gajendra Kumar; Amita Srivastava; Surinder Kumar Sharma; Yogendra Kumar Gupta
Journal: Ayu Date: 2012-04

8. Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis.

Authors: Charles Newman; Vamadevan S Ajay; Ravi Srinivas; Sandeep Bhalla; Dorairaj Prabhakaran; Amitava Banerjee
Journal: J Pharm Policy Pract Date: 2016-05-02

8 in total